The company has said it can have 180,000 treatment courses ready to ship this year and plans to produce at least 80 million more in 2022. Pfizer Inc on Tuesday said the final analysis of its antiviral COVID-19 pill still showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and recent lab data suggests the drug retains its …
Read More »US pharmaceutical giant Merck applies for emergency authorisation for Covid treatment pill
US pharmaceutical giant Merck said Monday that it has applied for emergency use authorization of its oral anti-Covid drug in the United States, a major step towards finding a simple pill to treat the disease.
Read More »